Family conflict
Related entities
Findings (50)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
declineBipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com
Effect: decline; F(6,383)=3.66 (anxiety x time interaction)
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29
None
improvementBipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to
Effect: improvement; F(6,382)=2.29